FranceOverall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 1,040 out of 208,384 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 23,103 | 21,121 |
| Total Cites | 16,229 | 19,123 |
| H-index | 61 | 69 |
| Hm-index | 24 | 26 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 126 | 152 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 4,947 | 5,590 |
| Number of Single+First+Last Authored Papers | 112 | 112 |
| Total Cites to Single+First+Last Authored Papers | 12,376 | 14,343 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8,774 | 9,334 |
| Ratio of Total Citations to Distinct Citing Papers | 1.85 | 2.05 |
| Self-Citation Percentage |
15.13%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 1,059 out of 201,173 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 21,266 | 19,291 |
| Total Cites | 14,383 | 17,073 |
| H-index | 60 | 67 |
| Hm-index | 23 | 25 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 112 | 137 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 4,352 | 4,957 |
| Number of Single+First+Last Authored Papers | 111 | 111 |
| Total Cites to Single+First+Last Authored Papers | 11,210 | 13,090 |
| Composite Score | 3 | 4 |
| Number of Distinct Citing Papers | 7,649 | 8,148 |
| Ratio of Total Citations to Distinct Citing Papers | 1.88 | 2.10 |
| Self-Citation Percentage |
15.76%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 1,052 out of 189,264 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 20,985 | 18,670 |
| Total Cites | 13,817 | 16,478 |
| H-index | 59 | 67 |
| Hm-index | 23 | 25 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 111 | 136 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 4,180 | 4,778 |
| Number of Single+First+Last Authored Papers | 109 | 109 |
| Total Cites to Single+First+Last Authored Papers | 10,819 | 12,683 |
| Composite Score | 3 | 4 |
| Number of Distinct Citing Papers | 7,357 | 7,839 |
| Ratio of Total Citations to Distinct Citing Papers | 1.88 | 2.10 |
| Self-Citation Percentage |
16.15%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 876 out of 135,836 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 20,886 | 19,033 |
| Total Cites | 12,528 | 15,114 |
| H-index | 56 | 63 |
| Hm-index | 22 | 23 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 101 | 126 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 3,751 | 4,344 |
| Number of Single+First+Last Authored Papers | 109 | 109 |
| Total Cites to Single+First+Last Authored Papers | 9,973 | 11,809 |
| Composite Score | 3 | 4 |
| Number of Distinct Citing Papers | 6,655 | 7,102 |
| Ratio of Total Citations to Distinct Citing Papers | 1.88 | 2.13 |
| Self-Citation Percentage |
17.11%
|
|
Trending Researchers
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.